Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-19-012471
Filing Date
2019-06-24
Accepted
2019-06-24 07:47:57
Documents
9
Effectiveness Date
2019-06-24

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A prog20190623_defa14a.htm DEFA14A 17032
2 slide1.jpg GRAPHIC 62252
3 slide2.jpg GRAPHIC 278602
4 slide3.jpg GRAPHIC 156075
5 slide4.jpg GRAPHIC 145379
6 slide5.jpg GRAPHIC 278352
7 slide6.jpg GRAPHIC 256652
8 slide7.jpg GRAPHIC 210060
9 slide8.jpg GRAPHIC 208465
  Complete submission text file 0001437749-19-012471.txt   2216746
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

EIN.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-23143 | Film No.: 19913326
SIC: 2834 Pharmaceutical Preparations